146 related articles for article (PubMed ID: 9778662)
1. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.
Schulteis G; Stinus L; Risbrough VB; Koob GF
Neuropsychopharmacology; 1998 Nov; 19(5):406-16. PubMed ID: 9778662
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
3. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
[TBL] [Abstract][Full Text] [Related]
4. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats.
Caillé S; Stinus L; Espejo EF; De Deurwaerdère P; Spampinato U; Koob GF
Neuropsychopharmacology; 2003 Feb; 28(2):276-83. PubMed ID: 12589380
[TBL] [Abstract][Full Text] [Related]
6. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine.
Kleven MS; Sparber SB
Pharmacol Biochem Behav; 1987 Oct; 28(2):235-41. PubMed ID: 2446338
[TBL] [Abstract][Full Text] [Related]
8. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
Kosten TA
Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
[TBL] [Abstract][Full Text] [Related]
9. Expression of c-Fos in the rat central amygdala accompanies the acquisition but not expression of conditioned place aversion induced by withdrawal from acute morphine dependence.
Jin C; Araki H; Nagata M; Shimosaka R; Shibata K; Suemaru K; Kawasaki H; Gomita Y
Behav Brain Res; 2005 Jun; 161(1):107-12. PubMed ID: 15904717
[TBL] [Abstract][Full Text] [Related]
10. Precipitated and conditioned withdrawal in morphine-treated rats.
Becker GL; Gerak LR; Li JX; Koek W; France CP
Psychopharmacology (Berl); 2010 Mar; 209(1):85-94. PubMed ID: 20127077
[TBL] [Abstract][Full Text] [Related]
11. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
12. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.
Caillé S; Espejo EF; Koob GF; Stinus L
Pharmacol Biochem Behav; 2002 Jul; 72(4):979-86. PubMed ID: 12062589
[TBL] [Abstract][Full Text] [Related]
13. Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats.
Sparber SB; Meyer DR
Pharmacol Biochem Behav; 1978 Sep; 9(3):319-25. PubMed ID: 568805
[TBL] [Abstract][Full Text] [Related]
14. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis.
Schulteis G; Markou A; Gold LH; Stinus L; Koob GF
J Pharmacol Exp Ther; 1994 Dec; 271(3):1391-8. PubMed ID: 7996451
[TBL] [Abstract][Full Text] [Related]
15. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
Streel E; Dan B; Campanella S; Meyvaert A; Hanak C; Pelc I; Verbanck P
Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582
[TBL] [Abstract][Full Text] [Related]
16. Effects of inactivating the agranular or granular insular cortex on the acquisition of the morphine-induced conditioned place preference and naloxone-precipitated conditioned place aversion in rats.
Li CL; Zhu N; Meng XL; Li YH; Sui N
J Psychopharmacol; 2013 Sep; 27(9):837-44. PubMed ID: 23784741
[TBL] [Abstract][Full Text] [Related]
17. Effects of morphine and morphine withdrawal on adrenergic neurons of the rat rostral ventrolateral medulla.
Baraban SC; Stornetta RL; Guyenet PG
Brain Res; 1995 Apr; 676(2):245-57. PubMed ID: 7542145
[TBL] [Abstract][Full Text] [Related]
18. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
Kleven MS; Sparber SB
J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
[TBL] [Abstract][Full Text] [Related]
19. Rapid induction of conditioned opiate withdrawal in the rat.
Baldwin HA; Koob GF
Neuropsychopharmacology; 1993 Jan; 8(1):15-21. PubMed ID: 8424845
[TBL] [Abstract][Full Text] [Related]
20. Effects of tizanidine administration on precipitated opioid withdrawal signs in rats.
Pinelli A; Trivulzio S; Spezia R
Drug Alcohol Depend; 1998 Mar; 50(1):81-8. PubMed ID: 9589275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
